ATE205705T1 - Arzneimittel zum wirkstoff - targetting in den dickdarm - Google Patents

Arzneimittel zum wirkstoff - targetting in den dickdarm

Info

Publication number
ATE205705T1
ATE205705T1 AT95103386T AT95103386T ATE205705T1 AT E205705 T1 ATE205705 T1 AT E205705T1 AT 95103386 T AT95103386 T AT 95103386T AT 95103386 T AT95103386 T AT 95103386T AT E205705 T1 ATE205705 T1 AT E205705T1
Authority
AT
Austria
Prior art keywords
colon
targetting
interest
active ingredients
medicinal product
Prior art date
Application number
AT95103386T
Other languages
English (en)
Inventor
Wantanee Phuapradit
Aruna Railkar
Navnit Hargovindas Shah
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE205705T1 publication Critical patent/ATE205705T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radar Systems Or Details Thereof (AREA)
AT95103386T 1994-03-23 1995-03-09 Arzneimittel zum wirkstoff - targetting in den dickdarm ATE205705T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/217,344 US5482718A (en) 1994-03-23 1994-03-23 Colon-targeted delivery system

Publications (1)

Publication Number Publication Date
ATE205705T1 true ATE205705T1 (de) 2001-10-15

Family

ID=22810676

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95103386T ATE205705T1 (de) 1994-03-23 1995-03-09 Arzneimittel zum wirkstoff - targetting in den dickdarm

Country Status (15)

Country Link
US (1) US5482718A (de)
EP (1) EP0673645B1 (de)
JP (1) JP2774080B2 (de)
CN (1) CN1112417A (de)
AT (1) ATE205705T1 (de)
AU (1) AU696943B2 (de)
CA (1) CA2142653A1 (de)
DE (1) DE69522729T2 (de)
DK (1) DK0673645T3 (de)
ES (1) ES2162874T3 (de)
NZ (1) NZ270737A (de)
PH (1) PH31334A (de)
PT (1) PT673645E (de)
RU (1) RU2138251C1 (de)
ZA (1) ZA952169B (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764697B1 (en) * 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
GB9412394D0 (en) 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
WO1998026767A2 (en) * 1996-12-17 1998-06-25 Poli Industria Chimica S.P.A. Site-specific controlled release dosage formulation for mesalamine
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US7220430B2 (en) * 2000-01-27 2007-05-22 Tanabe Seiyaku Co., Ltd. Sustained-release preparation and process for producing the same
JPWO2001078681A1 (ja) 2000-04-17 2004-01-08 山之内製薬株式会社 薬物動態学的な薬物相互作用を回避する薬物送達システム及びその方法
RU2188018C2 (ru) * 2000-06-20 2002-08-27 Нестерук Владимир Викторович Композиционный состав антибактериального лекарственного средства
IT1318625B1 (it) * 2000-07-14 2003-08-27 Roberto Valducci Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente.
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
WO2002072033A2 (en) * 2001-03-13 2002-09-19 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms containing glucocorticosteroid
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
AR036797A1 (es) * 2001-10-15 2004-10-06 Ferring Bv Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
GB0124953D0 (en) * 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
US20030133982A1 (en) * 2001-12-20 2003-07-17 Heimlich John M. Zero-order sustained release dosage forms and method of making same
JP2003238393A (ja) * 2002-02-15 2003-08-27 Otsuka Pharmaceut Co Ltd 施錠性が改善された錠剤及びその製造方法
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
WO2004093883A2 (en) 2003-04-23 2004-11-04 Ferring B.V. Sachet for a pharmaceutical composition
MXPA05011446A (es) 2003-04-24 2006-05-31 Jagotec Ag Tableta con liberacion retardada con geometria de nucleo definida.
US7825106B2 (en) * 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
JP2007504239A (ja) * 2003-09-03 2007-03-01 マリンクロッド・インコーポレイテッド 顆粒状持続放出製剤およびその製造
US7737133B2 (en) 2003-09-03 2010-06-15 Agi Therapeutics Ltd. Formulations and methods of treating inflammatory bowel disease
US20050118267A1 (en) * 2003-09-19 2005-06-02 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
AP2006003585A0 (en) * 2003-09-19 2006-04-30 Penwest Pharmaceuticals Co Delayed release dosage forms.
US7943585B2 (en) * 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
DE102004026706A1 (de) * 2004-05-28 2005-12-15 Merck Patent Gmbh Orale Darreichungsform enthaltend probiotische Bakterien
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
CN100366242C (zh) * 2005-01-13 2008-02-06 杭州容立医药科技有限公司 防滑脱阴道药物释放体系及其制造工艺和在制药中的应用
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
EA015304B1 (ru) 2006-08-03 2011-06-30 Нитек Фарма Аг Лечение ревматоидного заболевания глюкокортикоидами с отсроченным высвобождением
US20090028944A1 (en) * 2007-07-16 2009-01-29 Balaji Sathurappan Pharmaceutical compositions comprising mesalamine
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
GB0900350D0 (en) * 2009-01-09 2009-02-11 Cambridge Entpr Ltd Formulations of viable bacteria for oral delivery
CN102784203A (zh) * 2011-05-20 2012-11-21 上海凯宝药业股份有限公司 一种痰热清片剂及其制备方法
US10653631B2 (en) 2011-09-07 2020-05-19 Roland SAUR-BROSCH Optimal colon targeting technology
JP2014529630A (ja) 2011-09-07 2014-11-13 ザウラー−ブロシュ、ローラント 哺乳類の消化管における一つあるいは複数の物質の放出制御製剤
CN102319218B (zh) * 2011-09-22 2014-10-01 贝沃特医药技术(上海)有限公司 一种治疗肠道疾病的药物缓控释微粒制剂及其制备方法
US9763887B2 (en) 2013-03-15 2017-09-19 Allergan Pharmaceuticals International Limited Mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability
US10182993B2 (en) 2015-04-06 2019-01-22 Patheon Softgels Inc. Compositions for colonic delivery of drugs
WO2018193337A2 (en) 2017-04-18 2018-10-25 Actorius Innovations And Research Pvt. Ltd Polymer based formulation for release of drugs and bioactives at specific git sites
US11524029B2 (en) 2018-08-13 2022-12-13 Viscera Labs, Inc. Therapeutic composition and methods
US11590161B2 (en) 2018-08-13 2023-02-28 Viscera Labs, Inc. Therapeutic composition and methods
ES3002632T3 (en) 2018-12-07 2025-03-07 Tillotts Pharma Ag Delayed release drug formulation comprising an outerlayer with an enzymatically degradable polymer, its composition and its method of manufacturing
ES2994844T3 (en) * 2018-12-07 2025-02-03 Tillotts Pharma Ag Colonic drug delivery formulation
WO2021163007A1 (en) * 2020-02-12 2021-08-19 Viscera Labs, Inc. Therapeutic composition and methods
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions
WO2025215658A1 (en) * 2024-04-09 2025-10-16 Prabakaran Desomayanandam Pharmaceutical compositions of ketotifen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
US4668517A (en) * 1985-04-04 1987-05-26 Norwich Eaton Pharmaceuticals, Inc. Furazolidone dosage form
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
EP0253554A3 (de) * 1986-07-15 1988-07-20 Pfizer Inc. Arzneihaltige Fasern mit verzögerter Freisetzung
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US5225202A (en) * 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
IT1260505B (it) * 1992-06-01 1996-04-09 Poli Ind Chimica Spa Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon

Also Published As

Publication number Publication date
JP2774080B2 (ja) 1998-07-09
CA2142653A1 (en) 1995-09-24
ZA952169B (en) 1995-09-26
EP0673645B1 (de) 2001-09-19
NZ270737A (en) 1996-11-26
DK0673645T3 (da) 2001-11-12
PH31334A (en) 1998-07-06
DE69522729D1 (de) 2001-10-25
US5482718A (en) 1996-01-09
PT673645E (pt) 2002-03-28
ES2162874T3 (es) 2002-01-16
JPH07277958A (ja) 1995-10-24
RU2138251C1 (ru) 1999-09-27
DE69522729T2 (de) 2002-07-04
CN1112417A (zh) 1995-11-29
EP0673645A3 (de) 1996-07-24
AU696943B2 (en) 1998-09-24
EP0673645A2 (de) 1995-09-27
AU1488295A (en) 1995-10-05

Similar Documents

Publication Publication Date Title
ATE205705T1 (de) Arzneimittel zum wirkstoff - targetting in den dickdarm
MX9500885A (es) Preparacion farmaceutica para administracion oral.
EP0621032B1 (de) Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
DE69517218D1 (de) Kontrolliertes pharmazeutisches Präparat zur gezielten Freisetzung eines medizinischen Wirkstoffes im Intestinaltrakt
ATE261301T1 (de) Arzneizubereitungen enthaltend nicht-steroidale entzündungshemmende arzneimittel
DE69814122D1 (de) Darreichungsform zur verzögerten, vollständigen wirkstoffabgabe im verdauungstrakt
CA2335566A1 (en) Effervescent drug delivery system for oral administration
NZ237516A (en) Device for drug delivery to intestinal tract comprising a core of active ingredient together with osmotically activated expulsion agent and an outer coating containing a hydrophobic material to assist in delaying release
SG80553A1 (en) Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
EP1275381A4 (de) Feste überzogene zubereitungen mit zeitabhängiger freisetzung zur oralen verabreichung
RU2227033C2 (ru) Тауролидин и/или таурултам при лечении инфекционной язвенной болезни или инфекционного гастрита
ATE285228T1 (de) Arzneistoffverabreichungsystem zur verzögerten, völlstandigen wirkstoffabgabe im verdauungstrakt
ATE264670T1 (de) Eine pharmazeutische tablette charakterisiert durch hohen volumenzuwachs bei kontakt mit biologischen flüssigkeiten
FI933680A0 (fi) Orala doseringsformer foerdroejd frigoering foer behandling av tarmstoerningar
EP1123087A4 (de) Orales system zur verabreichung von gepulsten dosen eines arzneistoffs
PT825858E (pt) Capsulas de libertacao dependente do tempo contendo acidos poliinsaturados omega-3 para o tratamento da doenca inflamatoria do intestino
ATE279914T1 (de) Oral anzuwendendes arzneimittel zur wirkstoffverabreichung im magendarmtrakt
ATE290855T1 (de) Laminare arzneiform
Kumar et al. Colon specific drug delivery by pH sensitive polymers & pulsatile drug delivery system
TH22304A (th) สารเตรียมทางเภสัชกรรมแบบหลายหน่วยที่มีสารยัยยั้งปั๊มโปรตอน
US20040146554A1 (en) Method for the administration of acid-labile drugs

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee